Abstract
For almost 30 years, the National Cancer Institute (NCI) has sponsored health-related quality-of-life (HRQOL) measures in cancer research as a means of including the patient's experience. The scope of NCI's research in symptom management and HRQOL is described with attention to its evolution over time and the next steps, through the Clinical Trials Working Group Recommendations.
Original language | English (US) |
---|---|
Pages (from-to) | 5128-5132 |
Number of pages | 5 |
Journal | Journal of Clinical Oncology |
Volume | 25 |
Issue number | 32 |
DOIs | |
State | Published - Nov 10 2007 |
Externally published | Yes |
ASJC Scopus subject areas
- Oncology
- Cancer Research